Postprandial hyperglycemia was ameliorated by taking metformin 30 min before a meal than taking metformin with a meal; a randomized, open-label, crossover pilot study-Reference-Cited by-同舟云学术

Postprandial hyperglycemia was ameliorated by taking metformin 30 min before a meal than taking metformin with a meal; a randomized, open-label, crossover pilot study

Published:2015-10-30 Issue:2 Volume:52 Page:271-276
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Hashimoto Yoshitaka,Tanaka Muhei,Okada Hiroshi,Mistuhashi Kazuteru,Kimura Toshihiro,Kitagawa Noriyuki,Fukuda Takuya,Majima Saori,Fukuda Yukiko,Tanaka Yoshimitsu,Yamada Shunji,Senmaru Takafumi,Hamaguchi Masahide,Asano Mai,Yamazaki Masahiro,Oda Yohei,Hasegawa Goji,Nakamura Naoto,Fukui Michiaki

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-015-0786-4.pdf

Reference20 articles.

1. M.A. Espeland, H.A. Glick, A. Bertoni, F.L. Brancati, G.A. Bray, J.M. Clark, J.M. Curtis, C. Egan, M. Evans, J.P. Foreyt, S. Ghazarian, E.W. Gregg, H.P. Hazuda, J.O. Hill, D. Hire, E.S. Horton, V.S. Hubbard, J.M. Jakicic, R.W. Jeffery, K.C. Johnson, S.E. Kahn, T. Killean, A.E. Kitabchi, W.C. Knowler, A. Kriska, C.E. Lewis, M. Miller, M.G. Montez, A. Murillo, D.M. Nathan, E. Nyenwe, J. Patricio, A.L. Peters, X. Pi-Sunyer, H. Pownall, J.B. Redmon, J. Rushing, D.H. Ryan, M. Safford, A.G. Tsai, T.A. Wadden, R.R. Wing, S.Z. Yanovski, P. Zhang, Look AHEAD Research Group, Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care 37, 2548–2556 (2014)

2. M. Tominaga, H. Eguchi, H. Manaka, K. Igarashi, T. Kato, A. Sekikawa, Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22, 920–924 (1999)

3. T. Nakagami, Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47, 385–394 (2004)

4. F. Fehse, M. Trautmann, J.J. Holst, A.E. Halseth, N. Nanayakkara, L.L. Nielsen, M.S. Fineman, D.D. Kim, M.A. Nauck, Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 90, 5991–5997 (2005)

5. B. Balas, M.R. Baig, C. Watson, B.E. Dunning, M. Ligueros-Saylan, Y. Wang, Y.L. He, C. Darland, J.J. Holst, C.F. Deacon, K. Cusi, A. Mari, J.E. Foley, R.A. DeFronzo, The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 92, 1249–1255 (2007)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial;2023-09-07

2. Anti-Diabetic Effects of Cucurbitacins from Ibervillea lindheimeri on Induced Mouse Diabetes;Journal of Chemistry;2022-06-25

3. Combined Effect of Metformin and Statin;Metformin - Pharmacology and Drug Interactions;2021-12-15

4. Transcriptomic landscape profiling of metformin‐treated healthy mice: Implication for potential hypertension risk when prophylactically used;Journal of Cellular and Molecular Medicine;2020-06-11

5. Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action;Bioscience of Microbiota, Food and Health;2020